Binaytara Appoints New Leaders to Advance Cancer Education Initiatives

Binaytara has appointed two new leaders — Dr. Fengting Yan of Swedish Cancer Institute and Dr. Siddhartha Yadav of Mayo Clinic — to co-chair its Education Committee, advancing the organization’s mission to promote oncology education, continuing medical education (CME), and equitable cancer care worldwide. With 17 members representing leading U.S. cancer centers, this new team will guide Binaytara’s cancer education initiatives, fostering collaboration, innovation, and leadership in global oncology.

Binaytara is excited to introduce the newest class of its Education Committee, led by two new co-chairs, Dr. Fengting Yan of Swedish and Dr. Siddhartha Yadav of Mayo Clinic. This new class, comprising 17 members from leading cancer centers across the United States, is poised to elevate Binaytara’s oncology education initiatives. The committee will serve as the strategic backbone for educational excellence, focusing on four key pillars: strategic innovation, abstract review, faculty development, and contributions to flagship initiatives such as OncoBlast and The Cancer News.

Binaytara Strengthens Leadership in Oncology Education

For 17 years, Binaytara has been a leader in hematology and oncology continuing medical education, advancing patient care while addressing the disparities that often shape cancer outcomes. Guided by the CARE model, our strategic priorities include expanding and enhancing Cancer care centers, improving healthcare access and outcomes through Advocacy, fostering innovative Research in implementation science, and strengthening continuing Education programs. While these priorities are closely connected, the new Education Committee will focus specifically on strengthening continuing education through innovative and adaptive learning approaches. With a dynamic group of passionate oncologists and educators, the committee is set to infuse creativity and collaboration into every aspect of Binaytara’s educational mission.

The leadership of Dr. Yan and Dr. Yadav will be instrumental in achieving this goal. As the field of oncology continues to evolve, with new treatments and emerging technologies constantly reshaping cancer care, Binaytara’s commitment to advancing cancer education remains steadfast.

Dr. Fengting Yan: Advancing Women’s Cancer Education and CME Innovation

Dr. Fengting Yan, Co-Chair

Dr. Fengting Yan, a 2021, 2022, 2023, and 2025 Seattle Met Top Doctor Award recipient, brings deep expertise in personalized care and translational research in women’s cancers. At the Swedish Cancer Institute, she focuses on breast, cervical, endometrial, and ovarian cancers, integrating a strong “bench-to-bedside” approach that connects laboratory discoveries with patient care. Beyond the clinic, Dr. Yan is an active public educator who engages broad audiences on women’s health through various media platforms. She brings decades of experience in teaching, research, and oncology practice to Binaytara. Through her leadership in chairing CME conferences and serving on the editorial board of the International Journal of Cancer Care and Delivery (IJCCD), Dr. Yan’s new appointment to the Education Committee will further advance Binaytara’s mission of delivering novel and evidence-based oncology education.

Dr. Siddhartha Yadav: Bridging Research, Global Oncology, and Continuing Medical Education

Dr. Siddhartha Yadav, Co-Chair

Similarly, Dr. Yadav’s dedication to scholarship, clinical research, and global oncology is pivotal to Binaytara’s Education Committee. A former Binaytara board member and current member of the Binaytara Cancer Trust, Dr. Yadav has led multiple Binaytara conferences and is known for fostering intellectually stimulating discussions at these events. As an Assistant Professor of Oncology at the Mayo Clinic College of Medicine, he has authored over 50 scientific articles in high-impact journals, actively contributing to both educational initiatives and global oncology programs.

His research and clinical interests focus on breast and gynecological cancers, and he has received numerous awards, including the Young Investigator Award from ASCO and the Mayo Brothers Distinguished Fellowship Award. His leadership and experience are essential to positioning Binaytara as a provider of innovative and equitable oncology education.

Empowering Oncologists Through Innovative Cancer Education Initiatives

Our Education Committee is committed to staying ahead of the latest cancer research while simultaneously shaping the conversation around cancer management and delivery. Under the leadership of Dr. Yan and Dr. Yadav, the new class of Binaytara’s Education Committee will oversee more than 60 continuing medical education conferences in 2026, guiding how critical knowledge reaches healthcare professionals nationwide. Also, leading these initiatives are faculty from notable institutions, including Sarah Cannon Research Institute, Fred Hutchinson Cancer Center, Roswell Park Comprehensive Cancer Center, Huntsman Cancer Institute, and more. Explore the full roster of committee members and oncologists shaping the future of oncology education on Binaytara's Education Committee page.